Lexapro Formulary Position Secure Ahead Of Celexa Generics, Forest Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Forest is confident that the antidepressant Lexapro (escitalopram)will retain a favorable position on managed care formularies following the launch of generic versions of Celexa (citalopram)
You may also be interested in...
Forest's Lercanidipine Falls Short In Hypertension Trial
The calcium channel blocker "did not meet all the stringent preset criteria for dose response," and Forest plans to develop an alternative formulation. Company downgrades its earnings forecast following approval of Celexa generics; Forest's Inwood Labs division is marketing its own citalopram generic.
Forest's Lercanidipine Falls Short In Hypertension Trial
The calcium channel blocker "did not meet all the stringent preset criteria for dose response," and Forest plans to develop an alternative formulation. Company downgrades its earnings forecast following approval of Celexa generics; Forest's Inwood Labs division is marketing its own citalopram generic.
Celexa Generics Clear FDA
Five ANDAs for generic versions of Forest’s antidepressant approved; 180-day exclusivity was not available. Forest has been transitioning patients to the follow-on agent Lexapro.